NCT04376853View on ClinicalTrials.gov

CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
COVID-19
Interventions
DEVICE

Apple Watch Series 5

Digital monitoring via Apple Watch

Trial Locations (1)

69115

Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg

All Listed Sponsors
collaborator

The German Heart Foundation

OTHER

collaborator

Klaus Tschira Stiftung, Germany

UNKNOWN

collaborator

Freunde und Förderer der Kardiologie Heidelberg; Germany

UNKNOWN

lead

University Hospital Heidelberg

OTHER

NCT04376853 - CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch | Biotech Hunter | Biotech Hunter